CytomX Therapeutics Inc 6C1.DU Stock
1.76 EUR
{{ price }}
-1.067412%
{{change_pct}}%
COUNTRY
Germany
Exchange
Dusseldorf
Market Cap
0 EUR
LOW - HIGH [24H]
1.71
-
1.81 EUR
VOLUME [24H]
1.6K EUR
{{ volume }}
P/E Ratio
0
Earnings per share
0 EUR
CytomX Therapeutics Inc Price Chart
CytomX Therapeutics Inc 6C1.DU Financial and Trading Overview
| CytomX Therapeutics Inc stock price | 1.76 EUR |
| Previous Close | 1.4 EUR |
| Open | 1.4 EUR |
| Bid | 1.41 EUR x N/A |
| Ask | 1.44 EUR x N/A |
| Day's Range | 1.4 - 1.4 EUR |
| 52 Week Range | 1.12 - 2.84 EUR |
| Volume | 8K EUR |
| Avg. Volume | 186 EUR |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
6C1.DU Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
CytomX Therapeutics Inc Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 2.84 EUR |
| 52 Week Low | 1.12 EUR |
| 50-Day Moving Average | 1.52 EUR |
| 200-Day Moving Average | 1.69 EUR |
6C1.DU Share Statistics
| Avg. Volume (3 month) | 186 EUR |
| Avg. Daily Volume (10-Days) | 800 EUR |
| Shares Outstanding | N/A |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | N/A |
| Most Recent Quarter (mrq) | N/A |
| Next Fiscal Year End | N/A |
Profitability
| Profit Margin | N/A |
| Operating Margin (ttm) | N/A |
| Gross Margin | N/A |
| EBITDA Margin | N/A |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Q&A For CytomX Therapeutics Inc Stock
What is a current 6C1.DU stock price?
CytomX Therapeutics Inc 6C1.DU stock price today per share is 1.76 EUR.
How to purchase CytomX Therapeutics Inc stock?
You can buy 6C1.DU shares on the Dusseldorf exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for CytomX Therapeutics Inc?
The stock symbol or ticker of CytomX Therapeutics Inc is 6C1.DU.
How many shares does CytomX Therapeutics Inc have in circulation?
The max supply of CytomX Therapeutics Inc shares is 0.
What is CytomX Therapeutics Inc Price to Earnings Ratio (PE Ratio)?
CytomX Therapeutics Inc PE Ratio is now.
What was CytomX Therapeutics Inc earnings per share over the trailing 12 months (TTM)?
CytomX Therapeutics Inc EPS is 0 EUR over the trailing 12 months.